FDA outlines accelerated review guidelines in waning days of Biden administration
Teva announces agreement to divest Teva-Takeda, its business venture in Japan
Chasing Merck, BioNTech and DualityBio post first clinical data on ADC
What can we learn from 2024’s biotech IPOs?
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*
Teva announces agreement to divest Teva-Takeda, its business venture in Japan
Chasing Merck, BioNTech and DualityBio post first clinical data on ADC
What can we learn from 2024’s biotech IPOs?
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*